{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-008720","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.173300+00:00","generated_at":"2026-06-05T05:02:04.675913+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Ocean Biomedical appoints Jolie Kahn as CFO effective March 1; predecessor Kalra resigned Jan 30","bullets":["Gurinder Kalra resigned as CFO effective January 30, 2024 to pursue other interests.","Jolie Kahn was confirmed as CFO on March 1, 2024; she also serves as legal counsel to the company.","Kahn has corporate finance and securities law background; prior CFO roles at GlucoTrack (2019-2023) and interim CFO at ToughBuilt.","Compensation: $22,500 per month for CFO and counsel services."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-008720","json":"https://secwatch.observer/filing/0001493152-24-008720.json","markdown":"https://secwatch.observer/filing/0001493152-24-008720.md","text":"https://secwatch.observer/filing/0001493152-24-008720.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224008720/0001493152-24-008720-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224008720/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:02:04.675913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"48042bf00b","claim":"Jolie Kahn was appointed as Chief Financial Officer at Ocean Biomedical, Inc..","evidence_excerpt":"On March 1, 2024, the appointment of Jolie Kahn, as Chief Financial Officer of Ocean Biomedical, Inc. (the “Company”) was confirmed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224008720/0001493152-24-008720-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"7013f99aed","claim":"Gurinder Kalra resigned as Chief Financial Officer at Ocean Biomedical, Inc..","evidence_excerpt":"Ms. Kahn replaces Gurinder Kalra who resigned effective January 30, 2024 to pursue other interests.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224008720/0001493152-24-008720-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}